Method for treating a keloid with a botulinum toxin
Methods for treating melanin related afflictions by local administration of a Clostridial toxin, such as a botulinum toxin, to a patient with a melanin related affliction.
1. A method for treating a keloid in a patient in need thereof, the method comprising the step of administering botulinum toxin to the keloid, the amount of botulinum toxin administered being less than the amount needed to paralyze a muscle, to thereby treat the keloid.
2. The method of claim 1 , wherein the botulinum toxin is selected from the group consisting of botulinum toxin types A, B, C, D, E, F and G.
3. The method of claim 1 , wherein the botulinum toxin is a botulinum toxin type A.
4. The method of claim 1 , wherein the administration is by topical or subcutaneous administration of the botulinum toxin.
5. The method of claim 1 , wherein the keloid is reduced in size by from about 20% to 100%.
6. A method for treating a symptom associated with a keloid in a patient in need thereof, the method comprising the step of administering botulinum toxin to the keloid, the amount of botulinum toxin administered being less than the amount needed to paralyze a muscle, thereby treating a symptom associated with the keloid.
7. The method of claim 6 , wherein the botulinum toxin is selected from the group consisting of botulinum toxin types A, B, C, D, E, F and G.
8. The method of claim 6 , wherein the administration is by injection directly to the keloid.
9. The method of claim 6 , wherein the symptom is selected from the group consisting of pain, inflammation and vascularization.
10. The method of claim 6 , wherein administration is transdermal or subdermal or intradermal.
11. The method of claim 6 , wherein the administration is by a botulinum toxin implant.
12. A method for treating a keloid in a patient in need thereof, the method comprising the step of administering a botulinum toxin type A, the amount of botulinum toxin type A administered being less than the amount needed to paralyze a muscle, per administration site, per patient treatment session, to the keloid of the patient.
13. The method of claim 12 , wherein the administration is by injection directly to the keloid.
14. The method of claim 12 , wherein the administration is by topical or subcutaneous administration of the botulinum toxin.